An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth A Buy Here?

TalkMarkets - Mon, 01/05/2026 - 16:02
vTv Therapeutics is a $156 million biopharma focused on small molecule drugs for Alzheimer’s, diabetes, and inflammatory disorders, all in clinical trials.

Short Squeezes Are Brewing

TalkMarkets - Mon, 01/05/2026 - 15:53
When someone buys thousands of call contracts, market makers have to hedge by purchasing stock. That buying pressure forces shorts to cover, creating a feedback loop that can send prices soaring.

Market Talk - Monday, Jan. 5

TalkMarkets - Mon, 01/05/2026 - 15:45
The oil markets had a mixed day today.

Dow Notches Record Close With Help From Chevron

TalkMarkets - Mon, 01/05/2026 - 15:36
The Dow rose 595 points to secure a record close, earlier jumping above 49,000 for the first time ever.

Pages